Sanofi profit lifted by early vaccine sales, dupixent growth Ashleigh Furlong Fortune 1 0 25.10.2024 Earnings per share excluding some items reached €2.86 ($3.10) in the third quarter, exceeding analysts’ estimates.© Fortune visit website